445
As the euphoria brought on by passage of the U.S. Farm Bill begins to fade, American hemp stakeholders face the challenges of crafting and living with federal and state standards for cultivation and finished products. Some in the industry are eager to work with the U.S. Food & Drug Administration (FDA) to develop standards for hemp-based consumer products. Others threaten lawsuits.
Meanwhile, exponential growth, driven primarily by soaring demand for CBD, means many twists and turns ahead for hemp in the USA.